Tapemark

Tapemark Pharmaceuticals: Leading the Way in Transdermal, Oral Thin Film, and Unit Dose Semi-Solid Drug Delivery

Tapemark Pharmaceuticals is a full-service Contract Development and Manufacturing Organization (CDMO) that specializes in the development and manufacturing of transdermal patches, oral thin films, and unit dose semi-solid drug delivery systems. With over 60 years of experience in the pharmaceutical industry, Tapemark has established itself as a leader in drug delivery technology.

Transdermal patches are an innovative way to deliver drugs through the skin. They offer several advantages over traditional oral medications such as improved patient compliance, reduced side effects, and more consistent drug levels. Tapemark has developed a range of transdermal patches for various therapeutic areas including pain management, hormone replacement therapy (HRT), smoking cessation, and motion sickness.

Oral thin films are another area where Tapemark excels. These films dissolve quickly on the tongue or inside the cheek delivering medication directly into the bloodstream without having to pass through the digestive system. This method of drug delivery is particularly useful for patients who have difficulty swallowing pills or capsules.

Unit dose semi-solid drug delivery systems are yet another area where Tapemark has made significant strides. These systems provide accurate dosing while minimizing waste and reducing contamination risks associated with multi-use containers.

At Tapemark Pharmaceuticals we understand that every client's needs are unique which is why we offer customized solutions tailored to meet their specific requirements. Our team of experienced scientists works closely with clients from initial concept development through clinical trials to commercialization ensuring that their products meet regulatory requirements while maintaining quality standards.

Our state-of-the-art facilities located in West Saint Paul Minnesota USA feature cutting-edge equipment designed specifically for transdermal patch manufacturing including automated die-cutting machines capable of producing up to 1 million patches per day! We also have dedicated suites for oral thin film production equipped with high-speed coating machines capable of producing up to 10 million doses per year!

At Tapemark Pharmaceuticals we pride ourselves on our commitment to quality assurance which is why all our products undergo rigorous testing before they leave our facility ensuring that they meet or exceed industry standards.

In conclusion, if you're looking for a reliable partner who can help you develop innovative drug delivery solutions then look no further than Tapemark Pharmaceuticals! With our expertise in transdermal patch manufacturing, oral thin film production & unit dose semi-solid drug delivery systems coupled with state-of-the-art facilities & commitment to quality assurance - we're confident that we can help take your product from concept to commercialization successfully!